About
Technology
Issues
FAQ
Search
Scientometrics
Impact Factor
Discipline Ranks
h
-index
g
-index
Articles
Citations
Article Citations
Citation Distribution
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Journals
›
Cardiovascular Endocrinology and Metabolism
›
top-articles
Cardiovascular Endocrinology and Metabolism
1.9
(top 20%)
impact factor
144
(top 100%)
papers
746
(top 50%)
citations
13
(top 50%)
h
-index
2.0
(top 20%)
extended IF
158
all documents
848
doc citations
22
(top 50%)
g
-index
Top Articles
#
Title
Journal
Year
Citations
1
Estimating life years lost to diabetes: outcomes from analysis of National Diabetes Audit and Office of National Statistics data
Cardiovascular Endocrinology and Metabolism
2020
88
2
Development of clinical trials to extend healthy lifespan
Cardiovascular Endocrinology and Metabolism
2018
59
3
Atherosclerosis: integration of its pathogenesis as a self-perpetuating propagating inflammation: a review
Cardiovascular Endocrinology and Metabolism
2019
44
4
Pathophysiology of cardiovascular disease in diabetes mellitus
Cardiovascular Endocrinology and Metabolism
2018
35
5
Obese communities among the best predictors of COVID-19-related deaths
Cardiovascular Endocrinology and Metabolism
2020
26
6
The relationship between rheumatoid arthritis and diabetes mellitus: a systematic review and meta-analysis
Cardiovascular Endocrinology and Metabolism
2021
25
7
Relative fat mass is a better predictor of dyslipidemia and metabolic syndrome than body mass index
Cardiovascular Endocrinology and Metabolism
2019
22
8
Cardiovascular disease in type 1 diabetes
Cardiovascular Endocrinology and Metabolism
2019
22
9
Relative frequency of cardiology vs. endocrinology visits by type 2 diabetes patients with cardiovascular disease in the USA: implications for implementing evidence-based use of glucose-lowering medications
Cardiovascular Endocrinology and Metabolism
2020
20
10
Cardiometabolic disease in the older person: prediction and prevention for the generalist physician
Cardiovascular Endocrinology and Metabolism
2020
19
11
The early detection of atherosclerosis in type 1 diabetes: why, how and what to do about it
Cardiovascular Endocrinology and Metabolism
2019
18
12
Vascular disease in the lower limb in type 1 diabetes
Cardiovascular Endocrinology and Metabolism
2019
16
13
Comparing inpatient costs of heart failure admissions for patients with reduced and preserved ejection fraction with or without type 2 diabetes
Cardiovascular Endocrinology and Metabolism
2020
16
14
Coronary microvascular disease: current concepts of pathophysiology, diagnosis and management
Cardiovascular Endocrinology and Metabolism
2021
16
15
Pathogenesis and remission of type 2 diabetes: what has the twin cycle hypothesis taught us?
Cardiovascular Endocrinology and Metabolism
2020
15
16
Prevention and management of cardiovascular disease in patients with diabetes: current challenges and opportunities
Cardiovascular Endocrinology and Metabolism
2020
14
17
The acute vs. chronic effect of exercise on insulin sensitivity: nothing lasts forever
Cardiovascular Endocrinology and Metabolism
2021
14
18
Sodium-glucose co-transporter 2 inhibitors and diabetic retinopathy: insights into preservation of sight and looking beyond
Cardiovascular Endocrinology and Metabolism
2021
13
19
Is it infection or rather vascular inflammation? Game-changer insights and recommendations from patterns of multi-organ involvement and affected subgroups in COVID-19
Cardiovascular Endocrinology and Metabolism
2020
12
20
Cardiometabolic medicine – the US perspective on a new subspecialty
Cardiovascular Endocrinology and Metabolism
2020
12
21
The epidemiological status, environmental and genetic factors in the etiology of Keshan disease
Cardiovascular Endocrinology and Metabolism
2021
12
22
Cardioprotective diabetes drugs: what cardiologists need to know
Cardiovascular Endocrinology and Metabolism
2019
11
23
Androgen receptor-reduced sensitivity is associated with increased mortality and poorer glycaemia in men with type 2 diabetes mellitus: a prospective cohort study
Cardiovascular Endocrinology and Metabolism
2021
11
24
The role of OPG/RANKL in the pathogenesis of diabetic cardiovascular disease
Cardiovascular Endocrinology and Metabolism
2018
10
25
Recent trends over time in vascular disease in type 1 diabetes: insights from the Pittsburgh Epidemiology of Diabetes Complications study
Cardiovascular Endocrinology and Metabolism
2019
10
26
Association of lipid peroxidation and interleukin-6 with carotid atherosclerosis in type 2 diabetes
Cardiovascular Endocrinology and Metabolism
2019
10
27
Hypertension and diabetes mellitus in patients with COVID 19: a viewpoint on mortality
Cardiovascular Endocrinology and Metabolism
2020
9
28
Possible molecular and paracrine involvement underlying the pathogenesis of COVID-19 cardiovascular complications
Cardiovascular Endocrinology and Metabolism
2020
9
29
Effects of aerobic and anaerobic exercise on glucose tolerance in patients with coronary heart disease and type 2 diabetes mellitus
Cardiovascular Endocrinology and Metabolism
2020
9
30
The microvascular hypothesis underlying neurologic manifestations of long COVID-19 and possible therapeutic strategies
Cardiovascular Endocrinology and Metabolism
2021
9
31
Cardiometabolic medicine: time to recognize a new clinical specialty?
Cardiovascular Endocrinology and Metabolism
2019
8
32
The FreeStyle Libre flash glucose monitoring system: how it has improved glycaemic control for people with type 1 diabetes in Eastern Cheshire, UK
Cardiovascular Endocrinology and Metabolism
2020
8
33
Cardiovascular and cardiometabolic prevention: high-level priority in the era of COVID-19
Cardiovascular Endocrinology and Metabolism
2020
8
34
A treatment-based algorithm for identification of diabetes type in the National Health and Nutrition Examination Survey
Cardiovascular Endocrinology and Metabolism
2020
8
35
Clinical presentation of paroxysmal supraventricular tachycardia: evaluation of usual and unusual symptoms
Cardiovascular Endocrinology and Metabolism
2020
8
36
Type 2 diabetes prevalence in Pakistan: what is driving this? Clues from subgroup analysis of normal weight individuals in diabetes prevalence survey of Pakistan
Cardiovascular Endocrinology and Metabolism
2020
8
37
Exercise, cancer and cardiovascular disease: what should clinicians advise?
Cardiovascular Endocrinology and Metabolism
2021
8
38
Acute hyperglycemia and contrast-induced nephropathy in patients with non-ST elevation myocardial infarction
Cardiovascular Endocrinology and Metabolism
2020
6
39
Cardioprotective glucose-lowering medications: evidence and uncertainties in a new therapeutic era
Cardiovascular Endocrinology and Metabolism
2018
5
40
Diagnostic challenges in supraventricular tachycardia: anticipating value of natriuretic peptides
Cardiovascular Endocrinology and Metabolism
2018
5
41
Nonalcoholic fatty liver disease: implications for endocrinologists and cardiologists
Cardiovascular Endocrinology and Metabolism
2020
5
42
Exercise prescription in patients with type 2 diabetes and coronary heart disease: could less be more?
Cardiovascular Endocrinology and Metabolism
2020
5
43
Relationship between a single measurement at baseline of body mass index, glycated hemoglobin, and the risk of mortality and cardiovascular morbidity in type 2 diabetes mellitus
Cardiovascular Endocrinology and Metabolism
2020
5
44
Vitamin D status in acute myocardial infarction: a case–control study
Cardiovascular Endocrinology and Metabolism
2018
4
45
Interaction between cardiovascular autonomic control and sex hormones in perimenopausal women under menopausal hormone therapy
Cardiovascular Endocrinology and Metabolism
2018
4
46
Serum leptin in male hypothyroid prediabetic patients: Association with cardiovascular risk
Cardiovascular Endocrinology and Metabolism
2018
4
47
Milk and dairy foods: implications for cardiometabolic health
Cardiovascular Endocrinology and Metabolism
2018
4
48
Correlation between the serum procalcitonin level and the extension and severity of coronary artery disease in patients with non-ST-segment elevation myocardial infarction
Cardiovascular Endocrinology and Metabolism
2019
4
49
Vascular disease and type 2 diabetes: the science policy case for early cardiometabolic intervention
Cardiovascular Endocrinology and Metabolism
2019
4
50
Type 1 diabetes mellitus and coronary revascularization
Cardiovascular Endocrinology and Metabolism
2019
4
site/software ©
exaly
; All materials licenced under
CC by-SA
.